Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
We are seeking a highly motivated technical professional with a degree in Chemical or Biochemical Engineering (or related discipline) and at least three years of relevant industrial experience in platform-specific process development, process engineering, or manufacturing